1-5 of 5
Andrew L. Feldman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma

Available to Purchase
Waseem Lone, Alyssa Bouska, Sunandini Sharma, Catalina Amador, Mallick Saumyaranjan, Tyler A. Herek, Tayla B. Heavican, Jiayu Yu, Soon Thye Lim, Choon Kiat Ong, Graham W. Slack, Kerry J. Savage, Andreas Rosenwald, German Ott, James R. Cook, Andrew L. Feldman, Lisa M. Rimsza, Timothy W. McKeithan, Timothy C. Greiner, Dennis D. Weisenburger, Federica Melle, Giovanna Motta, Stefano Pileri, Julie M. Vose, Wing C. Chan, Javeed Iqbal
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (21): 6039–6053.
https://doi.org/10.1158/1078-0432.CCR-21-0573
Published: 01 November 2021
View articletitled, Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma
Open the PDF for Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells

Available to Purchase
Fatma Aboulnasr, Ashton Krogman, Rondell P. Graham, Nathan W. Cummins, Anisha Misra, Enrique Garcia-Rivera, Jeff R. Anderson, Sekar Natesampillai, Nicole Kogan, Murali Aravamudan, Zilin Nie, Thomas D.Y. Chung, Richard Buick, Andrew L. Feldman, Rebecca L. King, Anne J. Novak, Stephen M. Ansell, Saad Kenderian, Andrew D. Badley
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (21): 5759–5771.
https://doi.org/10.1158/1078-0432.CCR-20-0251
Published: 02 November 2020
View articletitled, Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells
Open the PDF for Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells in another window
Includes: Supplementary data
Journal Articles

Pattern of CD14+ Follicular Dendritic Cells and PD1+ T Cells Independently Predicts Time to Transformation in Follicular Lymphoma

Free
Jacob P. Smeltzer, Jason M. Jones, Steven C. Ziesmer, Deanna M. Grote, Bing Xiu, Kay M. Ristow, Zhi Zhang Yang, Grzegorz S. Nowakowski, Andrew L. Feldman, James R. Cerhan, Anne J. Novak, Stephen M. Ansell
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (11): 2862–2872.
https://doi.org/10.1158/1078-0432.CCR-13-2367
Published: 29 May 2014
View articletitled, Pattern of CD14+ Follicular Dendritic Cells and PD1+ T Cells Independently Predicts Time to Transformation in Follicular Lymphoma
Open the PDF for Pattern of CD14+ Follicular Dendritic Cells and PD1+ T Cells Independently Predicts Time to Transformation in Follicular Lymphoma in another window
Journal Articles

Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma

Free
Christian Gulmann, Virginia Espina, Emanuel Petricoin, III, Dan L. Longo, Mariarita Santi, Turid Knutsen, Mark Raffeld, Elaine S. Jaffe, Lance A. Liotta, Andrew L. Feldman
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 5847–5855.
https://doi.org/10.1158/1078-0432.CCR-05-0637
Published: 22 August 2005
View articletitled, Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma
Open the PDF for Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma in another window
Journal Articles

Serum Endostatin Levels Are Elevated and Correlate with Serum Vascular Endothelial Growth Factor Levels in Patients with Stage IV Clear Cell Renal Cancer

Free
Andrew L. Feldman, Lawrence Tamarkin, Giulio F. Paciotti, Byron W. Simpson, W. Marston Linehan, James C. Yang, William E. Fogler, Ewa M. Turner, H. Richard Alexander, Jr., Steven K. Libutti
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4628–4634.
Published: 01 December 2000
View articletitled, Serum Endostatin Levels Are Elevated and Correlate with Serum Vascular Endothelial Growth Factor Levels in Patients with Stage IV Clear Cell Renal Cancer
Open the PDF for Serum Endostatin Levels Are Elevated and Correlate with Serum Vascular Endothelial Growth Factor Levels in Patients with Stage IV Clear Cell Renal Cancer in another window